Clinical Trial Update: Efficacy and Safety Evaluating Study to Compare Kanarb (Fimasartan) and Cozaar® (Losartan) in Adult Patients With Grade I-II Arterial Hypertension [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Kanarb (fimasartan) to Cozaar (losartan) in adults with grade I-II arterial hypertension; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arterial Hypertension

Drugs mentioned

• Cozaar (losartan)
• Kanarb (Fimasartan)

Snippet

Sponsor: R-Pharm | Conditions: Arterial Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2019-05-06